This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Enzo Life Sciences
other brands :
Stressgen, BioMol, Alexis Corporation, Assay Designs, Alexis
product type :
antibody
product name :
Factor IX (human) monoclonal antibody (13B9)
catalog :
BPD-HYB-133-09-02
quantity :
200 µg
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
reactivity :
human
application :
western blot, ELISA
product information
Product ID :
BPD-HYB-133-09
Catalog Number :
BPD-HYB-133-09-02
Product Name :
Factor IX (human) monoclonal antibody (13B9)
Host species :
Mouse
Clonality :
Monoclonal
Product Type :
Antibody
Size :
200 µg
Clone :
13B9
Isotype :
IgG1κ
SPECIES REACTIVITY :
Human
Background :
Coagulation factor IX is a 57kDa single chain polypeptide, with a normal concentration in human plasma of approximately 3 µg/ml. Factor IX deficiency and lack of coagulation activity is seen in patients suffering from the innate X-chromosome linked disorder, haemophilia B.
ALTnames :
Christmas factor, Plasma thromboplastin component, PTC, Coagulation factor IX
Immunogen :
Human factor IX from plasma.
Buffer :
Liquid. In 0.01M phosphate buffer, pH 7.4, containing 0.5M sodium chloride and 15mM sodium azide.
Uses :
Detects a band of ~57kDa by Western blot.
Application Summary :
ELISA, WB
company information
Enzo Life Sciences
5777 Hines Drive
Ann Arbor, MI 48108
Ann Arbor, MI 48108
info-us@enzolifesciences.
https://www.enzolifesciences.com1-800-942-0430
headquarters: USA
Enzo Life Sciences, incorporating ALEXIS® Biochemicals and BIOMOL® International, offers a comprehensive panel of innovative life science reagents. Antibodies, enzymes, proteins, small molecule inhibitors, product libraries, and assay kits are available for research in Cancer, Cell Death, Epigenetics, Genomics, Immunology, Neuroscience, Signal Transduction, and Ubiquitin & Proteasomes, Enabling Discovery in Life Science(tm). Visit www.enzolifesciences.com.
questions and comments